Hoorie Masoorian

Hoorie Masoorian

Auto-generated profile, based on publicly available information

Hoorie Masoorian

Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Nanotoxicology
Verified
Journal Article
Closed access
AYAlireza Banaye Yazdipour
Alireza Banaye Yazdipour
HMHoorie Masoorian
Hoorie Masoorian
MAMahnaz Ahmadi
Mahnaz Ahmadi
NMniloofar mohammadzadeh
niloofar mohammadzadeh
SASeyed Mohammad Ayyoubzadeh
Seyed Mohammad Ayyoubzadeh
Nanoparticles have been used extensively in different scientific fields. Due to the possible destructive effects of nanoparticles on the environment or the biological systems, their toxicity evaluation is a crucial phase for studying nanomaterial safety. In the meantime, experimental approaches for toxicity assessment of various nanoparticles are expensive and time-consuming. Thus, an alternative technique, such as artificial intelligence (AI), could be valuable for predicting nanoparticle toxicity. Therefore, in this review, the AI tools were investigated for the toxicity assessment of nanomaterials. To this end, a systematic search was performed on PubMed, Web of Science, and Scopus databases. Articles were included or excluded based on pre-defined inclusion and exclusion criteria, and duplicate studies were excluded. Finally, twenty-six studies were included. The majority of the studies were conducted on metal oxide and metallic nanoparticles. In addition, Random Forest (RF) and Support Vector Machine (SVM) had the most frequency in the included studies. Most of the models demonstrated acceptable performance. Overall, AI could provide a robust, fast, and low-cost tool for the evaluation of nanoparticle toxicity.

30 November 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
AYAlireza Banaye Yazdipour
Alireza Banaye Yazdipour
SKSharareh R Niakan Kalhori
Sharareh R Niakan Kalhori
HBHassan Bostan
Hassan Bostan
HMHoorie Masoorian
Hoorie Masoorian
EAElham Ataee
Elham Ataee
HSHasan Sajjadi
Hasan Sajjadi
Introduction Cancer is a leading cause of death worldwide. In addition, it accounted for approximately 10 million deaths in 2020 alone. Information and communication technologies have great potential for improving health education and communication. Social media is one of the technologies that can help patients with cancer and healthcare providers communicate and provide educational information. Social media are increasingly being used for health promotion and behaviour change. This is a protocol of systematic review to identify the effect of social media interventions on the education and communication among patients affected by cancer. This study aims to reveal the steps of conducting research that systematically reviews all studies for the specific objective. This study aims to examine the social media interventions to improve awareness and knowledge about the disease for patients with cancer and improve communication among them. Methods and analysis This protocol is reported in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols checklist. We will include experimental design studies that report the effect of social media interventions on education and communication among patients with cancer or malignancy and any stage of the disease. Interventions will be inclusive, using all social network platforms for patients' communication and education. We will search PubMed, Web of Science, Scopus and the Cochrane Library from inception until 23 May 2022. Two independent reviewers will screen titles, abstracts and full-text articles with conflicts resolved through discussion or by a third reviewer, as needed. All titles, abstracts and full-text papers will be reviewed independently by two reviewers according to the inclusion and exclusion criteria. Discrepancies will resolve by discussion or SRNK if needed. The two reviewers will also independently complete risk of bias assessments for each included study. The descriptive analysis, including frequency and percentage parameters, will be calculated based on the study’s variables. Furthermore, we will report the results of the quality assessment of studies in table format. In the result section, a narrative synthesis will be applied to describe and compare the paper’s results. Ethics and dissemination Ethics approval will not be needed because the data to be used in this systematic review and meta-analysis will be extracted from published studies. It will be disseminated by publication in a peer-reviewed journal. PROSPERO registration number CRD42022334691.